Slides
Page 1
03.11.2026 Investor Relations Analyst presentation Third Quarter / Nine Months Figures 2026
Page 2
Investor Relations, 03.11.2026 Disclaimer Third Quarter / Nine Months Figures 20262 This presentation contains certain statements that are neither reported financial results nor other historical information. This presentation also includes forward-looking statements. Because these forward-looking statements are subject to risks and uncertainties, actual future results may differ materially from those expressed in or implied by the statements. Many of these risks and uncertainties relate to factors that are beyond Clariant’s ability to control or estimate precisely, such as future market conditions, geopolitical dislocation, currency fluctuations, the behavior of other market participants, the actions of governmental regulators, and other risk factors, such as: the timing and strength of new product offerings; pricing strategies of competitors; the Company’s ability to continue to receive adequate products from its vendors on acceptable terms, or at all, and to continue to obtain sufficient financing to meet its liquidity needs; and changes in the political, social, and regulatory framework in which the Company operates or in economic or technological trends or conditions, including currency fluctuations, inflation, and consumer confidence, on a global, regional, or national basis. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this document. Clariant does not undertake any obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date of these materials.
Page 3
Group performance
Page 4
Investor Relations, 03.11.2026 Third Quarter 2026 Third Quarter / Nine Months Figures 20264 1 FCF (Last Twelve Months) defined as cash generated from operating activities – Capex (investments in PPE and IA) 2 Defined as FCF / EBITDA 3 CC = Care Chemicals; CA = Catalysts; AA = Adsorbents & Additives 4 EBITDA before exceptionals Q3 2026: CHF 151.5 m (15.6 %); Q3 2025: CHF 162.0 m (17.9 %) Key messages Sales of CHF 968.8 m – strong growth in CC3 and AA (pricing and volumes) – CA continued to be impacted by Middle East (ME) conflict EBITDA b.e.i.4 margin 230 bps lower as continued improvement in AA offset by two effects of broadly similar magnitude: (1) positive phasing impact in Corporate costs in Q3 2025 (2) lower volume (CA) as well as business mix and effects of volatile raw materials on costs and valuation of inventory (CC and CA) 9 % pts FCF conversion improvement (Q3 LTM) achieved through improved operating cash flow, disciplined capex, and effective net working capital management Guidance FY 2026 remains unchanged with strong order book for the final quarter, particularly in Catalysts 48 % vs. 39 % in Q3 2025 (LTM) + 5.6 % vs. Q3 2025 15.6 % vs. 17.9 % in Q3 2025 EBITDA b.e.i. margin
Page 5
Investor Relations, 03.11.2026 Q3 sales:1 Strong pricing across all BUs with underlying volume growth in CC2 and AA; CA volumes remain impacted by Middle East conflict Third Quarter / Nine Months Figures 20265 905.9 905.9 956.4 956.4 956.4 956.4 968.8 Q3 2025 + 5.7 % Price - 0.1 % Volume 0.0 % Scope Currency3 Q3 2026 + 6.7 % LC excl. portfolio pruning + 5.6 % LC reported + 1.3 % Care Chemicals + 6.5 % Catalysts + 3.7 % Adsorbents & Additives + 5.4 % Care Chemicals + 0.1 % excl. portfolio pruning + 2.1 % Catalysts - 1.9 % Adsorbents & Additives + 1.0 % Main movers included INR (-), JPY (-), CNY (+), BRL (+), and USD (+) vs. reporting currency No impact 1 All references to local currency growth, pricing, volumes, and scope exclude the price impact from hyperinflation country Türkiye. 2 CC = Care Chemicals; CA = Catalysts; AA = Adsorbents & Additives 3 Currency translation impact includes the price impact from hyperinflation country Türkiye.
Page 6
Investor Relations, 03.11.2026 Third Quarter / Nine Months Figures 20266 Q3 EBITDA b.e.i.:1 Strong performance in AA offset by two effects of broadly similar magnitude across Corporate costs and businesses - 80 bps Care Chemicals - 110 bps Catalysts + 30 bps Adsorbents & Additives - 70 bps Corporate Q3 2026 b.e.i. 151.5 162.0 Q3 2025 b.e.i. Margin - 230 bps 17.9 % 1 EBITDA before exceptional items Contribution of performance improvement program and cost productivity 15.6 %Strong pricing and higher underlying volume growth offset by mix and effects of volatile raw materials on costs and valuation of inventory Middle East conflict impact (volumes), operating leverage, valuation effect on inventory and less favorable mix Strong pricing and volume Negative one-off 100 bps impact from phasing of provisions vs. the prior year, partially compensated by savings
Page 7
Investor Relations, 03.11.2026 Performance improvement programs (Investor Day 2024) achieve CHF 79 m run-rate savings, on track to deliver full CHF 100 m by 2027 Third Quarter / Nine Months Figures 20267 Programs – Savings: CHF 100 m total run-rate savings targeted of which CHF 79 m savings achieved, CHF 10 m savings in Q3 – Restructuring: CHF 99 m total restructuring charges (CHF 6 m in Q3) Key measures Q3 2026 – Headcount reduction of ~ 70 FTEs announced – total of ~ 700 FTEs announced – Execution of targeted cost management initiatives implemented across the BUs and Corporate functions 80 20 Investor Day 2024 Response 2026 2025 2026 2027 Run-rate savings of CHF 100 m through BU and Corporate actions by 2027 with 90 % contribution already to be achieved by FY 2026 Key levers: • SG&A reduction • Footprint optimization • Operational efficiency • Procurement programs FY 2025: CHF 50 m Q1: CHF 9 m Q2: CHF 10 m Increased targeted cost savings in BUs and Corporate functions Q3: CHF 10 m
Page 8
Q3 2026 Business performance
Page 9
Investor Relations, 03.11.2026 Third Quarter 2026 Care Chemicals Third Quarter / Nine Months Figures 20269 – Price: Strong increase related to time-lag of formula-based prices and continued successful implementation of value- based pricing – Volume: Underlying growth (+ 2.1 %) delivered by all segments except Oil Services (ME impact); strongest growth in industrial businesses (Industrial Applications, Base and Mining) and Personal & Home Care; Crop Solutions slightly lower – EBITDA b.e.i. margin:2 down 150 bps from mix effects and effects of volatile raw material prices on costs and valuation of inventory – Middle East impact for 2026: raw material costs to remain elevated and volatile in Q4; regional Oil Services demand impacted Strong growth driven by pricing in industrial businesses and Personal & Home Care 490.6 523.1 523.1 531.8 Q3 2025 + 6.5 % Price + 0.1 % Volume 0.0 % Scope + 1.8 % Currency / HIA Q3 2026 + 8.7 % LC excl. portfolio pruning + 6.6 % LC reported + 8.4 % 93.3 93.0 Q3 2025 b.e.i. Q3 2026 b.e.i. - 150 bps Sales1 (in CHF m) 19.0 % 17.5 % In LC Sales Q3 20263 Personal & Home Care DD + Crop Solutions Flat Industrial Applications DD + Base Chemicals DD + Oil Services DD -4 Mining Solutions HSD + EBITDA b.e.i.2 (margin) Segments 1 Currency translation impact includes the price impact from hyperinflation country Türkiye. 2 Before exceptional items 3 LSD = low-single-digit; DD = double-digit; HSD = high-single-digit. 4 LSD down, excluding portfolio pruning
Page 10
Investor Relations, 03.11.2026 1 Currency translation impact includes the price impact from hyperinflation country Türkiye. 2 Before exceptional items 3 LSD = low-single-digit ; DD = double-digit Third Quarter 2026 Catalysts Third Quarter / Nine Months Figures 202610 – Price: slightly up across the portfolio – Volume: significant Middle East impact continued with shift of high-margin orders (DD m); Propylene projects (Catofin ) vs. very low comparable base; Ethylene lower against high comparable base – EBITDA b.e.i. margin:2 down 580 bps due to Middle East impact, less favorable business mix, and valuation effect on inventory – Middle East impact for 2026: continued high levels of force majeures/shutdowns causing delays of refill orders; some normalization in Asia-Pacific – Strong order book and business mix into Q4 Positive pricing despite continued ME impact, high margin comparable 171.0 171.0 174.1 189.1 174.1 173.3 173.3 Q3 2025 + 3.7 % Price - 1.9 % Volume 0.0 % Scope - 0.5 % Currency / HIA Q3 2026 + 1.8 % + 1.3 % 32.7 23.1 Q3 2025 b.e.i. Q3 2026 b.e.i. - 580 bps EBITDA b.e.i.1 (margin) 19.1 % 13.3 % In LC Sales Q3 20263 Propylene > 2x + Ethylene DD - Syngas & Fuels LSD - Specialties Flat Segments Sales1 (in CHF m)
Page 11
Investor Relations, 03.11.2026 1 Currency translation impact includes the price impact from hyperinflation country Türkiye. 2 Before exceptional items 3 LSD = low-single-digit; DD = double-digit Margin improvement driven by strong top-line in Additives Third Quarter 2026 Adsorbents & Additives Third Quarter / Nine Months Figures 202611 – Price: up in all segments to offset inflationary raw materials (DD %) – Volume: strongly up in Additives driven by Polymer Solutions (Flame Retardants) and Coatings & Adhesives; Adsorbents slightly up with growth in renewable fuel applications in the US offsetting lower demand in industrial segments and edible oil purification in EMEA and APAC – EBITDA b.e.i. margin:2 110 bps increase due to positive mix effects, active margin management and performance improvement programs – Middle East impact for 2026: limited direct impact with uncertainty around year-end order pattern and global consumer demand in Q4 244.3 244.3 258.2 259.9 259.9 259.8 263.7 Q3 2025 + 5.4 % Price + 1.0 % Volume 0.0 % Scope + 1.5 % Currency / HIA Q3 2026 + 6.4 % + 7.9 % 42.5 48.9 Q3 2025 b.e.i. Q3 2026 b.e.i. + 110 bps 17.4 % 18.5 % In LC Sales Q3 20263 Adsorbents (51 %) LSD + Additives (49 %) DD + EBITDA b.e.i.1 (margin) Segments (split) Sales (in CHF m)
Page 12
Group Outlook
Page 13
Investor Relations, 03.11.2026 ~ flat sales growth in local currency1 (CHF 3.915 b in 2025; flat vs. PY) Guidance 2026 remains unchanged in challenging and volatile market environment impacted by Middle East conflict Third Quarter / Nine Months Figures 202613 2026 guidance (Q2) ~ 18.0 % EBITDA margin before exceptional items External factors – Middle East (ME) conflict with continued geopolitical challenges, uncertainties, and risks → negative impact mainly on CA and on ME Oil Services in CC – Global GDP growth stable at 2.6 % (vs. 2.5 % in July), global chemical industry growth negative to - 0.6 % (from 1.0 % in July) – No easing of interest rates; long-term rates remain elevated Internal factors – Portfolio pruning impact of negative ~ 1 % (Group) and ~ 2 % (CC) 2 – Growth in AA; slight growth in CC (underlying); CA expected lower (ME) – Value-based pricing to offset increased inflationary effects – Strong order book into Q4 in all Business Units, particularly Catalysts ~ flat sales growth in local currency1 2026 guidance (Q3) ~ 18.0 % EBITDA margin before exceptional items – Deliver cost savings of increased performance improvement programs – Increase in raw materials, energy, and logistics costs (pass-through) – General inflation ~ 3 - 4 %, driven by wages 1 All references to local currency exclude the price impact from hyperinflation country Türkiye; 2 CC = Care Chemicals; CA = Catalysts; AA = Adsorbents & Additives Clariant remains committed to medium-term targets, delivered by 2027 at the latest (17.8 % in 2025; up 180 bps vs PY)
Page 14
Appendix
Page 15
Investor Relations, 03.11.2026 Modeling guidance FY 2026 versus FY 2025 15 Third Quarter / Nine Months Figures 2026 Portfolio pruning • Divestments and closures create a negative top-line impact of 1 % (Group) and 2 % (Care Chemicals) to 2026 sales Sales guidance • Growth in Adsorbents & Additives • Slight underlying growth in Care Chemicals (catching up portfolio pruning effect) • Catalysts expected lower (Middle East postponements of refill activities) FX assumption • around 3 % headwind on sales (FY) Raw materials / energy / logistics • High single-digit percent up / double-digit percent up / double-digit percent up Performance improvement programs (Investor Day 2024) • CHF 79 m of CHF 100 m targeted run-rate cost savings achieved as of 9M2026; Total expectation of CHF 90 m in FY2026, with remainder expected in 2027 Capex • Lower end of targeted CHF 150 m – 175 m range Tax rate • 27 – 29 %
Page 16
Investor Relations, 03.11.2026 Third Quarter 2026 – Overview 16 Third Quarter / Nine Months Figures 2026 in CHF m Q3 2026 Q3 2025 % CHF % LC1 Sales 968.8 905.9 6.9 5.6 EBITDA 144.0 158.8 - 9.3 EBITDA margin 14.9 % 17.5 % EBITDA b.e.i.2 151.5 162.0 - 6.5 EBITDA b.e.i.2 margin 15.6 % 17.9 % Sales Bridge Price1 5.7 % Volume1 - 0.1 % Scope1 0.0 % Currency 1.3 % Group Care Chemicals Catalysts Adsorbents & Additives in CHF m Q3 2026 Q3 2025 % CHF % LC1 Sales 531.8 490.6 8.4 6.6 EBITDA 92.0 93.0 - 1.1 EBITDA margin 17.3 % 19.0 % EBITDA b.e.i.2 93.0 93.3 - 0.3 EBITDA b.e.i.2 margin 17.5 % 19.0 % Sales Bridge Price1 6.5 % Volume1 0.1 % Scope1 0.0 % Currency 1.8 % Sales Split Consumer 58 % Industrial 42 % in CHF m Q3 2026 Q3 2025 % CHF % LC1 Sales 173.3 171.0 1.3 1.8 EBITDA 23.3 32.5 - 28.3 EBITDA margin 13.4 % 19.0 % EBITDA b.e.i.2 23.1 32.7 - 29.4 EBITDA b.e.i.2 margin 13.3 % 19.1 % Sales Bridge Price1 3.7 % Volume1 - 1.9 % Scope1 0.0 % Currency - 0.5 % Sales Split Petrochemicals 28 % Syngas 40 % Specialties 32 % in CHF m Q3 2026 Q3 2025 % CHF % LC1 Sales 263.7 244.3 7.9 6.4 EBITDA 41.8 42.7 - 2.1 EBITDA margin 15.9 % 17.5 % EBITDA b.e.i.2 48.9 42.5 15.1 EBITDA b.e.i.2 margin 18.5 % 17.4 % Sales Bridge Price1 5.4 % Volume1 1.0 % Scope1 0.0 % Currency 1.5 % Sales Split Consumer 49 % Industrial 51 % Additives 49 % Adsorbents 51 % 1 All references to local currency growth, pricing, volumes, and scope exclude the price impact from hyperinflation country Türkiye; 2 Before exceptional items
Page 17
Investor Relations, 03.11.2026 First Nine Months 2026 – Overview 17 Third Quarter / Nine Months Figures 2026 in CHF m 9M 2026 9M 2025 % CHF % LC1 Sales 2 828.1 2 886.6 -2.0 1.0 EBITDA 444.2 449.9 -1.3 EBITDA margin 15.7 % 15.6 % EBITDA b.e.i.2 482.8 520.9 -7.3 EBITDA b.e.i.2 margin 17.1 % 18.0 % Sales Bridge Price1 2.2 % Volume1 - 1.2 % Scope1 0.0 % Currency - 3.0 % Group Care Chemicals Catalysts Adsorbents & Additives in CHF m 9M 2026 9M 2025 % CHF % LC1 Sales 1 582.1 1 586.4 -0.3 2.1 EBITDA 302.4 276.9 9.2 EBITDA margin 19.1 % 17.5 % EBITDA b.e.i.2 311.8 310.2 0.5 EBITDA b.e.i.2 margin 19.7 % 19.6 % Sales Bridge Price1 2.2 % Volume1 - 0.1 % Scope1 0.0 % Currency - 2.4 % Sales Split Consumer 59 % Industrial 41 % in CHF m 9M 2026 9M 2025 % CHF % LC1 Sales 492.1 551.2 -10.7 -5.1 EBITDA 63.2 104.1 -39.3 EBITDA margin 12.8 % 18.9 % EBITDA b.e.i.2 68.7 107.7 -36.2 EBITDA b.e.i.2 margin 14.0 % 19.5 % Sales Bridge Price1 1.6 % Volume1 - 6.7 % Scope1 0.0 % Currency - 5.6 % Sales Split Petrochemicals 33 % Syngas 36 % Specialties 31 % in CHF m 9M 2026 9M 2025 % CHF % LC1 Sales 753.9 749.0 0.7 3.0 EBITDA 129.1 126.4 2.1 EBITDA margin 17.1 % 16.9 % EBITDA b.e.i.2 142.7 139.9 2.0 EBITDA b.e.i.2 margin 18.9 % 18.7 % Sales Bridge Price1 2.8 % Volume1 0.2 % Scope1 0.0 % Currency - 2.3 % Sales Split Consumer 50 % Industrial 50 % Additives 48 % Adsorbents 52 % 1 All references to local currency growth, pricing, volumes, and scope exclude the price impact from hyperinflation country Türkiye; 2 Before exceptional items
Page 18
Investor Relations, 03.11.2026 Q3 sales CHF 968.8 m in CHF m, % in local currency1 Geographic split Third Quarter / Nine Months Figures 202618 Americas 287.2 / + 2.8 % EMEA 392.1 / + 6.1 % Asia-Pacific 289.5 / + 7.7 % Germany 91.6 / + 11.4 % 1 All references to local currency growth, pricing, volumes, and scope exclude the price impact from hyperinflation country Türkiye; 2 BU = Business Unit; CC = Care Chemicals; CA = Catalysts; AA = Adsorbents & Additives; LSD = low single-digit; MSD = mid-single-digit; HSD = high single-digit; DD = double-digit; MDD = mid double-digit, LDD = low double-digit 40.5 % 29.6 % 29.9 % BU2 Q3 sales CC HSD + CA MSD + AA MSD + BU2 Q3 sales CC HSD + CA DD + AA LSD + BU2 Q3 sales CC MSD + CA LDD - AA DD + China 87.7 / - 8.0 % USA 162.2 / + 6.5 % Brazil 67.1 / + 11.0 % 9M sales CHF 2 828.1 m in CHF m, % in local currency1 Americas 809.4 / - 3.7 % EMEA 1 192.8 / - 0.9 % Asia-Pacific 825.9 / + 8.7 % Germany 300.1 / + 2.9 % 42.2 % 28.6 % 29.2 % BU2 9M sales CC LSD + CA DD - AA Flat BU2 9M sales CC HSD + CA DD + AA HSD + BU2 9M sales CC Flat CA LDD - AA LSD + China 281.7 / - 2.5 % USA 471.9 / + 1.4 % Brazil 173.8 / - 4.4 %
Page 19
Investor Relations, 03.11.2026 Third Quarter / Nine Months Figures 202619 − Raw materials in Q3 up 12.0 % YoY (sequential up 2.4 %) − Energy in Q3 up 9.0 % YoY (sequential up 2.9 %) − Logistics in Q3 up 23.7 % YoY (sequential up 5.8 %) − Low-growth economic environment with inflationary raw materials, energy, and logistics in Q3 2026 − Q3 Pricing: 5.7 % (sequential 0.9 %) − Q3 Volumes: - 0.1 % (sequential down 0.3 %) Cost dynamics – year on year and sequentially mixed Strong pricing and volumes stable around the flat line 8 % 17 % - 1 % - 1 % 7 % 7 % - 7 % FY 21 FY 22 0 % FY 23 - 2 % FY 24 0 % FY 25 - 0.5 % - 1.5 % Q1 26 3.0 % - 3.3 % Q2 26 - 0.1 % 5.7 % Q3 26 Volume Pricing 21 % 25 % 2 % 2 % 7 % 12 % 18 % 35 % 6 % 9 % 21 % 6 % 24 % FY 21 FY 22 - 20 % - 13 % - 11 % FY 23 - 3 % - 7 % FY 24 - 10 % - 1 % FY 25 - 9 % - 5 % Q1 26 8 % Q2 26 Q3 26 - 5 % Logistics Energy Raw Materials
Page 20
Investor Relations, 03.11.2026 Exposure to attractive consumer markets of close to 50 %... …with accelerating demand for sustainable products Third Quarter / Nine Months Figures 202620 Sales by end market 2021 (Total Group) Sales by end market Q3 LTM 20261 Industrial 47 % Consumer 36 % Chemical Process (Catalysts) 17 % Other Industrial > 5 % Mining ~ 5 % Aviation < 5 % Building & Construction < 5 % Automotive ~ 10 % Oil ~ 10 % Consumer Home & Personal Care ~ 20 % Coatings & Adhesives ~ 10 % Agriculture & Food < 10 % Electrical & Electronics < 5 % Industrial Industrial 35 % Consumer 45 % Chemical Process (Catalysts) 20 % 1 Last Twelve Months (Q4 2025 – Q3 2026)
Page 21
Investor Relations, 03.11.2026 ESG – Clariant’s sustainability transformation commitment 21 Third Quarter / Nine Months Figures 2026 Sustainability priorities Investment in operations and portfolio Zero waste and pollution Eliminating waste and pollution from our operations and value chains Sustainable bio-economy Creating a sustainable bio-economy by protecting nature and maintaining high social standards Increasing circularity Products and solutions that enable reducing, reusing, and recycling Social value creation Creating value for our employees, in our business networks, and in society as a whole Safe and sustainable in everything we do Fighting climate change Reducing our own carbon footprint and creating value for customers with low-carbon, high-performing solutions Sustainable operations Future-proof our operations for a climate- neutral, sustainable world Sustainability-driven portfolio change Increase the safety and sustainability of our products and help our customers achieve their sustainability goals
Page 22
Investor Relations, 03.11.2026 Clariant’s leading sustainability ratings and rankings Third Quarter / Nine Months Figures 202622 Status as of September 2026 Index / Ranking / Rating Clariant Score / Percentile Rank or Range Status / Comments First Year of Inclusion 2015AA to A with 2026 Methodology Update (review ongoing)A / Range: AAA to CCC 22.2 (Medium Risk) Climate (CC): A (Range: A to D-) Water (WS): A (Range: A to D-) Forests (F): A (Range: A to D-) Top 10 % of companies in its Specialty Chemicals subindustry Out of 22 000 companies, only 26 earn Triple A status 2016 2013 B- / Top 10 % 3.9 / 73rd Percentile 79 / 92nd Percentile 60 / 100 - "Advanced" "Prime" Status and Industry Leader Included in FTSE4 Good Index – 2013 2015 2012 2014 Rank | Percentile Subindustry (Specialty Chemicals) Industry (Chemicals) 70 / 577 | 13th 15 / 155 | 10th 2% 5% 7% 19% 20% 27% 19% CCC B BB BBB A AA AAA A A- B B- C C- D D- – Overall Score 79/ 100
Page 23
Investor Relations, 03.11.2026 Reducing corporate GHG emissions Significant improvement of non-financial KPIs – fully on track to deliver updated 2030 greenhouse gas (GHG) targets Third Quarter / Nine Months Figures 202623 New operating model driving customer satisfaction and employee engagement – Safety as #1 priority – Safety ▪ Commitment to achieve a zero-accidents culture ▪ LTM Q3 2026: TRIR rate at 0.37 flat vs. 0.34 at FY 2025; DART rate at 0.18 vs. 0.13 in FY 2025; continued high awareness, safety trainings, and accountability ▪ Top-quartile performance in the chemical industry – Employee engagement survey ▪ All employees invited to an engagement survey in Jan. 2026 ▪ Participation rate increased from 86 % to 88 % ▪ Employee engagement at 87 % – top quartile vs. industry peers ▪ Employee engagement score increased to + 37 in 2026 compared to + 34 in 2025 – Customer satisfaction ▪ Customer Net Promoter Score (cNPS) increased to 50 in 2025 vs. 45 in 2024 ▪ Outstanding scores for “product quality,” “technical support,” and “customer service” ▪ Positions Clariant in the top quartile among peers 46.9 % reduction in Scope 1 & 2 emissions 0.75 0.54 0.49 0.43 0.42 0.40 2019 2023 2024 LTM Q3 2026 Target 2030 2025 - 2.3 % Scope 1 & 2 GHG emissions in m tCO2e, corresponding to – 43.6 % since 2019 Scope 3.1 & 3.12 GHG emissions in m tCO2e, corresponding to – 30.6 % since 2019 5.19 4.08 4.01 3.73 3.60 3.76 2019 2023 2024 2025 LTM Q3 2026 Target 2030 - 3.5 % New baseline New baseline In 2024, Clariant performed a rebaselining exercise, reflecting the latest climate science and structural changes to the company since the 2019 baseline was developed. Based on the new baseline, Clariant has updated its near-term company-wide emission reductions to be consistent with the Paris Agreement goals that aim to limit global warming to 1.5°C. The updated near-term targets were reviewed and approved by SBTi in 2025. 27.5 % reduction in Scope 3.1 & 3.12 emissions
Page 24
Investor Relations, 03.11.2026 Calendar of Upcoming Corporate Events Third Quarter / Nine Months Figures 202624 29 October 2027 Third Quarter / Nine Months 2027 Reporting 23 February 2027 Fourth Quarter / Full Year 2026 Reporting 7 April 2027 Annual General Meeting 2027 29 April 2027 First Quarter 2027 Reporting 30 July 2027 Second Quarter / Half Year 2027 Reporting
Page 25
Investor Relations, 03.11.2026 The Executive Leadership Team Third Quarter / Nine Months Figures 202625 Conrad Keijzer Chief Executive Officer Executive Leadership Team Executive Steering Committee Jens Cuntze Business President CA & APAC Angela Cackovich Business President AA & EMEA Priya Thaman Chief Human Resources Officer Judith Bischof General Counsel Richard Haldimann Chief Strategy & Technology Officer Marcelo Lu Business President CC & Americas Oliver Rittgen Chief Financial Officer
Page 26
Investor Relations, 03.11.2026 IR contacts Third Quarter / Nine Months Figures 202626 ANDREAS SCHWARZWÄLDER Head of Investor Relations Phone: +41 61 469 63 73 Email: investor-relations@clariant.com THIJS BOUWENS Investor Relations Officer Phone: +41 61 469 63 73 Email: investor-relations@clariant.com
Page 27
Thank you We place great value on understanding the current views of our investment community. Therefore, we would greatly appreciate your input and feedback via www.clariant.com/Investors/Feedback. Your information will be collected via the secure platform of QuantiFire, who manages this process on our behalf.